Neximmune (NEXI) Stock Price, News & Analysis
Company Description
Neximmune (OTC Link: NEXI) is classified in the biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $4.1M, ranking #6,977 among all listed U.S. companies by market cap.
NEXI has gained 0.0% over the past year. Shares last traded at $0.0001.
For FY2023, Neximmune reported net income of -$32.3M and diluted earnings per share of $-30.82.
This page collects what Stock Titan holds for NEXI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neximmune (NEXI) stock last closed at $0.0001. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $4.1M, NEXI is classified as a micro-cap stock.
NEXI Rankings
Latest News
Neximmune has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include offering, partnership, stock split, earnings, clinical trial. View all NEXI news →
SEC Filings
Financial Highlights
operating income reached -$33.0M, and net income was -$32.3M. Diluted earnings per share stood at $-30.82. The company generated -$31.4M in operating cash flow. With a current ratio of 1.06, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Neximmune (NEXI) currently stands at 112 shares, representing 0.0% of the float. Since July 2025, short interest has decreased by 96.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Neximmune (NEXI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 98.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 365.8 days.
NEXI Company Profile & Sector Positioning
Neximmune (NEXI) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing NEXI often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Eloxx Pharmaceut (ELOX), Gritstone Bio Inc (GRTSQ), Effector Therapeutics Inc (EFTR), and Innoveren Scientific Inc (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NEXI's relative position within its industry.